<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/61B5E6D6-02CE-4BD5-A1E9-773F980F3F74"><gtr:id>61B5E6D6-02CE-4BD5-A1E9-773F980F3F74</gtr:id><gtr:name>Syntaxin</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3DB3C69-F0E5-4B6A-8B33-1EC7352E6CA2"><gtr:id>F3DB3C69-F0E5-4B6A-8B33-1EC7352E6CA2</gtr:id><gtr:name>University of California Davis</gtr:name><gtr:address><gtr:line1>1 Shields Avenue</gtr:line1><gtr:line4>Davis</gtr:line4><gtr:line5>CA 95616</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Biomedical Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/61B5E6D6-02CE-4BD5-A1E9-773F980F3F74"><gtr:id>61B5E6D6-02CE-4BD5-A1E9-773F980F3F74</gtr:id><gtr:name>Syntaxin</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3DB3C69-F0E5-4B6A-8B33-1EC7352E6CA2"><gtr:id>F3DB3C69-F0E5-4B6A-8B33-1EC7352E6CA2</gtr:id><gtr:name>University of California Davis</gtr:name><gtr:address><gtr:line1>1 Shields Avenue</gtr:line1><gtr:line4>Davis</gtr:line4><gtr:line5>CA 95616</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4595878D-6166-4746-9780-0DD6A5B8F304"><gtr:id>4595878D-6166-4746-9780-0DD6A5B8F304</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Dockray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0717324F-C451-4E55-AD77-EEA0204FB1CB"><gtr:id>0717324F-C451-4E55-AD77-EEA0204FB1CB</gtr:id><gtr:firstName>Rod</gtr:firstName><gtr:surname>Dimaline</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5772C072-313B-427A-BB34-FE2437834B08"><gtr:id>5772C072-313B-427A-BB34-FE2437834B08</gtr:id><gtr:firstName>Alastair</gtr:firstName><gtr:surname>Watson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G8714277"><gtr:id>8D6FBCD7-4865-4ADB-9D3B-B931A3B0204C</gtr:id><gtr:title>The endocrinology of the upper gastrointestinal tract</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G8714277</gtr:grantReference><gtr:abstractText>Diseases of the upper digestive tract include cancer of the stomach, and peptic ulcer. Worldwide, stomach cancer accounts for about 500,000 deaths each year. Drugs that reduced stomach acid cost the health service in this country about #500M per year. We propose to study a hormone, gastrin, that is known to control acid production and the ability of the stomach to produce acid. Recent work suggests that there is a complex mixture of different forms of gastrin that have different actions; some of these substances may also regulate processes that determine the development of stomach cancer. We propose experiments to define the relevant mechanisms. We will work with cells obtained from the stomach of normal human subjects, and with experimental mice in which some of the genes for proteins known to be involved in these processes have been mutated. We want to understand more about how the cells of the stomach are enabled to produce acid, how the stomach protects itself from acid and how it responds to a bacterium called Helicobacter pylori (which in some people may cause stomach cancer, or ulcers in the duodenum). Using, in part, information derived from the human genome sequence, we have recently found several previously unsuspected genes that are implicated in these processes, and that we propose to study in more detail. This information should help in understanding the best way for clinicians to manage individual patients who are at risk of developing these diseases. The results will be published in the normal scientific way; important discoveries will be disseminated through press releases. In the past, the applicants have been asked from time to time to provide expert information to the media, and they will continue to do this drawing on their own recent research experience.</gtr:abstractText><gtr:technicalSummary>Diseases of the upper gastrointestinal tract including gastric cancer and acid-peptic disorders are a major burden on health and a major cost to health services. The hormone gastrin acutely regulates acid secretion, and determines the capacity for acid secretion by regulating parietal cell maturation. Recent work suggests an unexpectedly diverse family of active products generated from the gastrin gene. Moreover, a number of new target genes have been identified that are regulated by gastrin and that may be involved in mucosal organisation. We propose experimental studies (a) to define the physiological role in the stomach of peptides generated from the gastrin precursor, (b) to determine the mechanisms by which gastrin induces gene expression in primary cells, and (c) to characterise endocrine and paracrine regulated events in the gastric mucosa that determine mucosal organisation.</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1988-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3566778</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Davis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Veterinary Medicine Davis</gtr:department><gtr:description>Gut-brain signalling</gtr:description><gtr:id>322D7082-464E-45D7-8581-2149305703A0</gtr:id><gtr:impact>See:
De Lartigue et al., 2010, Gastroenterology.
De Lartigue et al., 2010, Endocrinology</gtr:impact><gtr:outcomeId>SBsmiVJBGjF-1</gtr:outcomeId><gtr:partnerContribution>Provision of experimental expertise</gtr:partnerContribution><gtr:piContribution>Initiated the collaboration, provided strategic direction, and contributed some of the data acquisition and analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Syntaxin</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Control of gastrin secretion</gtr:description><gtr:id>6518A11B-6A73-4809-AFEB-B3F64F351807</gtr:id><gtr:impact>Syntaxin have fully supported a postgraduate research studentship. The support has allowed us to study gastrin cell function in more detail and to seek novel ways to inhibit gastrin secretion.</gtr:impact><gtr:outcomeId>09A309E61DD-1</gtr:outcomeId><gtr:partnerContribution>Syntaxin have fully supported a postgraduate research studentship. The support has allowed us to study gastrin cell function in more detail and to seek novel ways to inhibit gastrin secretion.</gtr:partnerContribution><gtr:piContribution>We have performed all the studies investigating the action of materials prepared by the commercial partner on gastrin release.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Briefings</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>516D2AFF-278B-40D7-85D1-B30BC25038B7</gtr:id><gtr:impact>Discussion with policymakers with respect to obesity/food intake.

Results of the discussion incorporated into final reports from BBSRC, and from Chief Scientific Officer.</gtr:impact><gtr:outcomeId>9F42BF7FDE2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keynote lectures</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>1CB464F9-AF56-4AF4-93DE-D60140C7A36F</gtr:id><gtr:impact>Several keynote lectures for up to an hour to large and varied audiences. Positive feedback.

Requests for futher information.</gtr:impact><gtr:outcomeId>48E4554F469</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>North West Cancer Research (NWCR)</gtr:fundingOrg><gtr:id>1DC23158-12AE-425C-9300-5D10351434F3</gtr:id><gtr:outcomeId>263D5816B040</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>170000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH Centre (in collaboration)</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>7DFBEA56-125E-48E1-B139-4197475621E4</gtr:id><gtr:outcomeId>6310CB8BA350</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Liverpool Pancreatic Biomedical Research Unit</gtr:department><gtr:description>NIHR Biomedical Research Centre</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>05B484F9-5B37-42D6-8B88-A653FB3B6AB7</gtr:id><gtr:outcomeId>30EC8B36F800</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>294722</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Actions of cholecystokinin on vagal afferent neurons)</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>7B935194-5E0D-42A2-A75D-8143F0F473DB</gtr:id><gtr:outcomeId>ZYcVLBSRK4g0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>290000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>European Society of Intensive Care Medicine (ESICM)</gtr:fundingOrg><gtr:id>0DCEDF5A-77A2-4901-B0B0-709E0650C412</gtr:id><gtr:outcomeId>98946E48EE40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We developed methods for long term culturing of myofibroblasts from gastric cancer and adjacent normal tissue.</gtr:description><gtr:id>7D719EE1-D59C-4B55-A16D-F85E9C5009CE</gtr:id><gtr:impact>Several groups, including our own, now recognise this method as key to studying the role of stromal cells in oncogenesis.</gtr:impact><gtr:outcomeId>3C919100AFE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Myofibroblasts</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EC224B91-0EF2-4C28-AD17-839CA9981D66</gtr:id><gtr:title>Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68e70f7c58cb592aa404dadd3602a4c1"><gtr:id>68e70f7c58cb592aa404dadd3602a4c1</gtr:id><gtr:otherNames>Burdyga G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>996D4CD11BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2828E147-D532-4FF5-9F2C-B1F42C5CE165</gtr:id><gtr:title>Feeding-dependent depression of melanin-concentrating hormone and melanin-concentrating hormone receptor-1 expression in vagal afferent neurones.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68e70f7c58cb592aa404dadd3602a4c1"><gtr:id>68e70f7c58cb592aa404dadd3602a4c1</gtr:id><gtr:otherNames>Burdyga G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>566713C9356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C19568CA-A22E-4CBE-A363-CFA4A67D6057</gtr:id><gtr:title>Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/537453d9dae8528aaa71e3c059beb461"><gtr:id>537453d9dae8528aaa71e3c059beb461</gtr:id><gtr:otherNames>de Lartigue G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>6E4C822DE48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD10A9B4-3512-4A56-B361-185F6D3D8622</gtr:id><gtr:title>The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fd7b81d706dc804540be08c3dee655a"><gtr:id>6fd7b81d706dc804540be08c3dee655a</gtr:id><gtr:otherNames>McCaig C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>A1E8B8CE0EA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>162D3786-9503-433D-8FB1-C85650A84AD3</gtr:id><gtr:title>Identification of a gastrin response element in the vesicular monoamine transporter type 2 promoter and requirement of 20 S proteasome subunits for transcriptional activity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e102d12d4e14491f263ab89fce7d65a2"><gtr:id>e102d12d4e14491f263ab89fce7d65a2</gtr:id><gtr:otherNames>Catlow K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>E2DCA9C4E88</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC55381A-463E-4CBF-84C6-F63E6319DC56</gtr:id><gtr:title>Identification of ezrin as a target of gastrin in immature mouse gastric parietal cells.</gtr:title><gtr:parentPublicationTitle>Experimental physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131480b5426dca2b9024114b3bc3cce4"><gtr:id>131480b5426dca2b9024114b3bc3cce4</gtr:id><gtr:otherNames>Pagliocca A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0958-0670</gtr:issn><gtr:outcomeId>5FEEAB80A77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01381709-7AAB-4C50-ABC5-2BD4500FC6C0</gtr:id><gtr:title>Cocaine- and amphetamine-regulated transcript mediates the actions of cholecystokinin on rat vagal afferent neurons.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a150a23ad2930d3b57471fc354545e3b"><gtr:id>a150a23ad2930d3b57471fc354545e3b</gtr:id><gtr:otherNames>De Lartigue G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>Y95WMBkwYLH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A4B2D7-8739-48D6-A5C1-52BC71CC37EB</gtr:id><gtr:title>Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa69c2a2ed4816253e69602de0002504"><gtr:id>fa69c2a2ed4816253e69602de0002504</gtr:id><gtr:otherNames>Varro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>D4BB0F024C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD5CC82D-7108-479B-8B80-F12ABBACE988</gtr:id><gtr:title>Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5128a16a2fc0d725de38c76ab9359b7"><gtr:id>e5128a16a2fc0d725de38c76ab9359b7</gtr:id><gtr:otherNames>Steele IA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>13BFE2D1115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>509718CF-F1AB-4507-8E08-FFC0A8624538</gtr:id><gtr:title>EGR1 Is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/537453d9dae8528aaa71e3c059beb461"><gtr:id>537453d9dae8528aaa71e3c059beb461</gtr:id><gtr:otherNames>de Lartigue G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>VB7wfUzu1de</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>758A563F-DBE5-412F-9ABB-6BE2B947E6F8</gtr:id><gtr:title>Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/504a041fc6dfa5e1e4b7667f727df563"><gtr:id>504a041fc6dfa5e1e4b7667f727df563</gtr:id><gtr:otherNames>Kenny S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>B6594B30F41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C70A6BD-3FF5-4F2D-9B9F-FBF9D6B27713</gtr:id><gtr:title>Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68e70f7c58cb592aa404dadd3602a4c1"><gtr:id>68e70f7c58cb592aa404dadd3602a4c1</gtr:id><gtr:otherNames>Burdyga G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>2CBB6D03A3B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DCBD0CE-B5E5-434F-9CAB-69D321640A5A</gtr:id><gtr:title>Gastrin increases murine intestinal crypt regeneration following injury.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/579c68b8f16d424a9d20c101bcb027e4"><gtr:id>579c68b8f16d424a9d20c101bcb027e4</gtr:id><gtr:otherNames>Ottewell PD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>46C59C1D8EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A45150D-E49E-4100-8F39-8D11A8B8B52E</gtr:id><gtr:title>Gastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/741d63386790c0e2d03c5a0234d9a190"><gtr:id>741d63386790c0e2d03c5a0234d9a190</gtr:id><gtr:otherNames>Almeida-Vega S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>B2DE2BF3315</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G8714277</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>